Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.






Org chart

Robert Blum
President & CEO

Robert Blum

Fady I. Malik
EVP, Research and Development
Andrew Callos
EVP, Chief Commercial Officer
Andrew A. Wolff
SVP, Senior Fellow, Clinical Research and Development
Ching W. Jaw
SVP, Chief Financial Officer
Stuart Kupfer
SVP, Chief Medical Officer
Kari K. Loeser
VP, Chief Compliance Officer
John Faurescu
Associate General Counsel & Corporate Secretary
Bonnie A. Charpentier
SVP, Regulatory Affairs and Compliance
Diane Weiser
SVP, Corporate Communications and Investor Relations
Anne N. Murphy
VP, Biology
Daniel E. Kates
VP, Medical Affairs
Daniel R. Casper
VP, Information Technology
Eric Terhaerdt
SVP, Development Operations
Erin Donnelly
VP, Portfolio & Project Management
Lisa Meng
VP, Biometrics
Norma Tom
VP, Chemistry, Manufacturing and Control
Christine Murray
SVP, Regulatory & Quality
Yulymae Dinapoli
VP, Human Resources
Richey Neuman
VP, Medical Affairs
John Jacoppi
VP, US Marketing for Aficamten
Joseph Dagher
SVP & Head, Europe
Megan Truong
VP, Quality
Katia Finck
VP, Head of Market Access Europe
Prodromous Anthopoulos
VP, Head of Medical Affairs Europe